Middle-East and Africa Hypertension Drugs Market Global Leading Companies Analysis, Revenue

Market Highlights

The Middle-East and Africa Hypertension Drugs Market has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. Factors like Stress, unhealthy eating habits, excess use of salt, smoking, and alcohol mainly leads to hypertension. Hypertension or high blood pressure is very harmful and it can damage brain, heart, and kidney as well. High blood pressure can also lead to medical emergencies like stroke and heart attack. Medical professionals recommend drugs as per the current condition of the patient. There are some symptoms of high blood pressure like headache, blood in urine, anxiety etc. Cases of hypertension are growing rapidly in Middle East and Africa. 

Request Sample Copy:


Rising consumer awareness and continuous development of treatment for Hypertension are driving the growth for the Middle-East and Africa Hypertension Drugs market. Major companies are investing amount of money for R&D to find cure for Hypertension. As the number of patients of increasing thus demand for the anti-hypertensive is also increasing rapidly. Increasing spending for healthcare, developing infrastructure, and expanded insurance coverage are leading the growth for Middle-East and Africa Hypertension Drugs. Middle-East and Africa Hypertension Drugs Market was estimated around US$ 4.52 billion in 2015 and is expected to reach US$ 5.31 billion by 2022 at a CAGR of 3.1%. There are several factors which are prohibiting the growth of the market such as high cost of treatment and drugs, lack of early treatment, people mostly from some African countries are not much aware about the symptoms of high blood pressure etc.

Hypertension Drugs Market Players:

Abbott (US), Johnson & Johnson Services, Inc. (US), Novartis (Switzerland), GlaxoSmithKline plc. (UK), AstraZeneca (UK), Bayer AG (Germany), Pfizer Inc.(US), Merck & Co., Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Gilead (US)

Regional Analysis:

Considering the Middle-East and Africa Hypertension Drugs Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Hypertension Drugs. Moreover Saudi Arabia market is also growing and second largest market for Hypertension Drugs. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Hypertension Drugs during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.


Middle-East and Africa Hypertension Drugs Market has been segmented on the basis of type which comprise Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers, Calcium channel blockers, Renin inhibitors, Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators, Aldosterone antagonists, and others.

Access Report Details @ 


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

Be the first to comment

Please check your e-mail for a link to activate your account.